Live wire

Live biotech news wire

Every readout, FDA decision, financing, filing and halt across the 718-stock universe, as it crosses. This page updates itself every 30 seconds; leave it open. Scroll back through the wire, or search a ticker to pull everything it has crossed. The source filters mute whole categories, like SEC filings, or individual sites; the page remembers your choices on this device.

LIVElast updated

Sources

Untick a site to hide everything from it. Choices are remembered on this device and apply to new items as they arrive.

5:25 PM EST

APVO

8-K - Aptevo Therapeutics Inc. (0001671584) (Filer)

filingsec_edgar

5:21 PM EST

AKTX

8-K - Akari Therapeutics Plc (0001541157) (Filer)

filingsec_edgar

5:21 PM EST

FATE

424B5 - FATE THERAPEUTICS INC (0001434316) (Filer)

financingsec_edgar

5:20 PM EST

BGMS

424B3 - Bio Green Med Solution, Inc. (0001130166) (Filer)

financingsec_edgar

5:16 PM EST

LSTA

S-3 - LISATA THERAPEUTICS, INC. (0000320017) (Filer)

financingsec_edgar

5:11 PM EST

LGVN

8-K - Longeveron Inc. (0001721484) (Filer)

filingsec_edgar

5:11 PM EST

TLPH

S-3 - TALPHERA, INC. (0001427925) (Filer)

financingsec_edgar

5:04 PM EST

QNRX

8-K - Quoin Pharmaceuticals Ltd. (0001671502) (Filer)

filingsec_edgar

5:01 PM EST

PRAX

8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer)

filingsec_edgar

5:00 PM EST

BGMS

8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)

filingsec_edgar

5:00 PM EST

CLLS

6-K - Cellectis S.A. (0001627281) (Filer)

filingsec_edgar

4:48 PM EST

S-3 - Equillium, Inc. (0001746466) (Filer)

financingsec_edgar

4:45 PM EST

GRML

8-K - Greenland Mines Ltd (0001907223) (Filer)

filingsec_edgar

4:45 PM EST

STRO

8-K - SUTRO BIOPHARMA, INC. (0001382101) (Filer)

filingsec_edgar

4:43 PM EST

SPRO

8-K - Spero Therapeutics, Inc. (0001701108) (Filer)

filingsec_edgar

4:41 PM EST

RLYB

8-K - Rallybio Corp (0001739410) (Filer)

filingsec_edgar

4:40 PM EST

DMAC

8-K - DiaMedica Therapeutics Inc. (0001401040) (Filer)

filingsec_edgar

4:39 PM EST

HOWL

424B3 - Werewolf Therapeutics, Inc. (0001785530) (Filer)

financingsec_edgar

4:37 PM EST

NVS

6-K - NOVARTIS AG (0001114448) (Filer)

filingsec_edgar

4:35 PM EST

TPST

8-K - Tempest Therapeutics, Inc. (0001544227) (Filer)

filingsec_edgar

4:34 PM EST

PEPG

8-K - PepGen Inc. (0001835597) (Filer)

filingsec_edgar

4:31 PM EST

PRAX

Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day

corporateglobenewswire

4:31 PM EST

PRFX

6-K - PRF Technologies Ltd. (0001801834) (Filer)

filingsec_edgar

4:30 PM EST

OLMA

8-K - Olema Oncology, Inc. (0001750284) (Filer)

filingsec_edgar

4:30 PM EST

TRIB

6-K - TRINITY BIOTECH PLC (0000888721) (Filer)

filingsec_edgar

4:30 PM EST

PEPG

424B5 - PepGen Inc. (0001835597) (Filer)

financingsec_edgar

4:30 PM EST

ELDN

Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights

corporateglobenewswire

4:30 PM EST

STRO

Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights

corporateglobenewswire

4:30 PM EST

AZTR

Azitra, Inc. Announces Q3 2026 Results and Provides Business Updates

corporatepr_newswire_health

4:30 PM EST

ZYBT

Zhengye Biotechnology Holding Limited Announces Financial Results for the First Six Months of Fiscal Year 2026

corporatepr_newswire_health

4:27 PM EST

VRCA

8-K - Verrica Pharmaceuticals Inc. (0001660334) (Filer)

filingsec_edgar

4:26 PM EST

CADL

8-K - Candel Therapeutics, Inc. (0001841387) (Filer)

filingsec_edgar

4:25 PM EST

KALA

8-K - KALA BIO, Inc. (0001479419) (Filer)

filingsec_edgar

4:25 PM EST

NKTR

8-K - NEKTAR THERAPEUTICS (0000906709) (Filer)

filingsec_edgar

4:24 PM EST

ARMP

8-K - Armata Pharmaceuticals, Inc. (0000921114) (Filer)

filingsec_edgar

4:23 PM EST

EVMN

424B3 - Evommune, Inc. (0002044725) (Filer)

financingsec_edgar

4:22 PM EST

CADL

424B5 - Candel Therapeutics, Inc. (0001841387) (Filer)

financingsec_edgar

4:22 PM EST

ENSC

8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)

filingsec_edgar

4:21 PM EST

CRDF

8-K - Cardiff Oncology, Inc. (0001213037) (Filer)

filingsec_edgar

4:21 PM EST

CRDL

6-K - Cardiol Therapeutics Inc. (0001702123) (Filer)

filingsec_edgar

4:20 PM EST

RANI

8-K - Rani Therapeutics Holdings, Inc. (0001856725) (Filer)

filingsec_edgar

4:20 PM EST

PCRX

8-K - Pacira BioSciences, Inc. (0001396814) (Filer)

filingsec_edgar

4:20 PM EST

SCTX

8-K - Scribe Therapeutics, Inc. (0001853921) (Filer)

filingsec_edgar

4:19 PM EST

SER

Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates

corporateglobenewswire

4:17 PM EST

PMN

8-K - ProMIS Neurosciences Inc. (0001374339) (Filer)

filingsec_edgar

4:17 PM EST

PROK

8-K - PROKIDNEY CORP. (0001850270) (Filer)

filingsec_edgar

4:17 PM EST

ETRA

8-K - Electra Therapeutics, Inc. (0002088082) (Filer)

filingsec_edgar

4:16 PM EST

VIR

424B5 - Vir Biotechnology, Inc. (0001706431) (Filer)

financingsec_edgar

4:16 PM EST

ANAB

8-K - ANAPTYSBIO, INC (0001370053) (Filer)

filingsec_edgar

4:16 PM EST

RNA

8-K - Atrium Therapeutics, Inc. (0002093101) (Filer)

filingsec_edgar

4:16 PM EST

OBX

424B3 - Obsidian Therapeutics, Inc. (0002130606) (Filer)

financingsec_edgar

4:15 PM EST

VNRX

8-K - VOLITIONRX LTD (0000093314) (Filer)

filingsec_edgar

4:15 PM EST

RCKT

8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)

filingsec_edgar

4:15 PM EST

NBTX

Voting Rights and Shares Capital of the Company

corporateir_newsrooms

4:15 PM EST

CBIO

8-K - CRESCENT BIOPHARMA, INC. (0001253689) (Filer)

filingsec_edgar

4:15 PM EST

BLSM

8-K - BlossomHill Therapeutics, Inc. (0001839970) (Filer)

filingsec_edgar

4:15 PM EST

AZTR

8-K - Azitra, Inc. (0001701478) (Filer)

filingsec_edgar

4:15 PM EST

IMMX

8-K - Immix Biopharma, Inc. (0001873835) (Filer)

filingsec_edgar

4:15 PM EST

NBTX

6-K - Nanobiotix S.A. (0001760854) (Filer)

filingsec_edgar

4:15 PM EST

IMMX

Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

corporateglobenewswire

4:15 PM EST

BGMS

BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

corporateglobenewswire

4:15 PM EST

VRCA

Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results

corporateglobenewswire

4:15 PM EST

NKTR

Nektar Therapeutics Announces Third Quarter 2026 Financial Results

corporatepr_newswire_health

4:14 PM EST

NTLA

8-K - Intellia Therapeutics, Inc. (0001652130) (Filer)

filingsec_edgar

4:13 PM EST

SER

8-K - Serina Therapeutics, Inc. (0001708599) (Filer)

filingsec_edgar

4:13 PM EST

SLXN

8-K - Silexion Therapeutics Corp (0002022416) (Filer)

filingsec_edgar

4:11 PM EST

PLUR

S-3/A - Pluri Inc. (0001158780) (Filer)

financingsec_edgar

4:11 PM EST

BOLT

8-K - Bolt Biotherapeutics, Inc. (0001641281) (Filer)

filingsec_edgar

4:11 PM EST

BCDA

8-K - BioCardia, Inc. (0000925741) (Filer)

filingsec_edgar

4:11 PM EST

MGNX

8-K - MACROGENICS INC (0001125345) (Filer)

filingsec_edgar

4:11 PM EST

FDMT

8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)

filingsec_edgar

4:11 PM EST

PLRX

8-K - PLIANT THERAPEUTICS, INC. (0001746473) (Filer)

filingsec_edgar

4:11 PM EST

ALMS

8-K - ALUMIS INC. (0001847367) (Filer)

filingsec_edgar

4:10 PM EST

NCNA

6-K - NuCana plc (0001709626) (Filer)

filingsec_edgar

4:10 PM EST

ZYBT

6-K - Zhengye Biotechnology Holding Ltd (0001975641) (Filer)

filingsec_edgar

4:10 PM EST

RLMD

8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)

filingsec_edgar

4:10 PM EST

FULC

8-K - Fulcrum Therapeutics, Inc. (0001680581) (Filer)

filingsec_edgar

4:10 PM EST

LCTX

8-K - Lineage Cell Therapeutics, Inc. (0000876343) (Filer)

filingsec_edgar

4:10 PM EST

8-K - Equillium, Inc. (0001746466) (Filer)

filingsec_edgar

4:10 PM EST

ELDN

8-K - Eledon Pharmaceuticals, Inc. (0001404281) (Filer)

filingsec_edgar

4:10 PM EST

CBIO

Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights

corporateglobenewswire

4:10 PM EST

VNRX

VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update

corporatepr_newswire_health

4:10 PM EST

RNA

Atrium Therapeutics Reports Third Quarter 2026 Financial Results

readoutpr_newswire_health

4:08 PM EST

ERAS

8-K - Erasca, Inc. (0001761918) (Filer)

filingsec_edgar

4:07 PM EST

OBX

8-K - Obsidian Therapeutics, Inc. (0002130606) (Filer)

filingsec_edgar

4:05 PM EST

STTK

Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

corporateglobenewswire

4:05 PM EST

SCTX

Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

corporateglobenewswire

4:01 PM EST

ERAS

Erasca Reports Third Quarter 2026 Business Updates and Financial Results

corporateir_newsroomsseen 9:09 PM EST

2:50 PM EST

PMCB

Trading halt: $PMCB - PharmaCyte Biotech, Inc. Cm (NASDAQ) - news pending [T1], still halted

haltnasdaq_haltsseen 7:50 PM EST

5:00 PM EST

TVTX

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

corporateir_newsroomsseen 8:41 PM EST

4:54 PM EST

LGVN

Longeveron Announces 2026 Third Quarter Financial Results and Provides Business Update

corporateir_newsroomsseen 8:18 PM EST

7:00 AM EST

RLMD

Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

corporateglobenewswireseen 4:11 PM EST

Nov 11, 7:00 PM EST

BIIB

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease

corporateir_newsroomsseen 6:32 PM EST

Nov 11, 7:00 PM EST

IOVA

Iovance Biotherapeutics to Present at Upcoming Conference

corporateir_newsroomsseen 5:38 PM EST

Nov 11, 7:00 PM EST

PRAX

Read Full Press Release

corporateir_newsroomsseen 4:33 PM EST

Nov 11, 7:00 PM EST

MANE

Veradermics to Present at the Jefferies Global Healthcare Conference in London

corporateir_newsroomsseen 4:33 PM EST

Nov 11, 7:00 PM EST

PRME

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

financingir_newsroomsseen 4:17 PM EST

Nov 11, 7:00 PM EST

ENSC

Ensysce Biosciences Reports Third Quarter 2026 Financial Results and Business Highlights

corporateir_newsroomsseen 4:15 PM EST

Nov 11, 7:00 PM EST

PROK

ProKidney Reports Third Quarter 2026 Financial Results and Business Highlights

corporateir_newsroomsseen 4:12 PM EST

Sep 29, 8:00 PM EDT

ANAB

Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update

corporateir_newsroomsseen 4:17 PM EST

No items match the current filters.